EFGCP Conference 2026

Uniting for Success: A Multi-stakeholder Vision for Ethical Review in Europe

Description

Event Conference
Type Hybrid
Language English
Date(s) 12&13 May 2026
Day(s) 2 Day(s)
Duration 0.5 Day x 2

Europe is at a defining moment for clinical research. The Clinical Trials Regulation set out a powerful vision: a continent united by transparency, collaboration, and efficient access to innovation. While its implementation brought both progress and pressure, it confirmed something essential—Europe’s commitment to ethics, quality, and patient protection remains unwavering.

National ethical review is a vital strength of Europe’s clinical research landscape. Ethics committees play a key role in ensuring trials uphold human dignity, scientific integrity, and public trust. Their contribution, together with the regulatory authorities' risk-benefit review, forms the foundation of a credible and high‑quality research ecosystem. By further strengthening the collaborative partnership, Europe can achieve an ethical review process that is both protective and efficiently aligned with the needs of modern clinical research.

Today, national ethical review stands at the centre of the conference discussion. Ethics committees face growing complexity; sponsors navigate longer reviews and more information requests. These challenges highlight not failure, but opportunity: the chance to rethink how Europe aligns ethical excellence with operational efficiency.

In addition, the European Commission’s proposed new Biotech Act offers a fresh pathway—clearer roles, streamlined processes, and modern ethical standards grounded in the 2024 Declaration of Helsinki. It invites us to shape a system worthy of Europe’s innovation leadership ambitions.

The EFGCP Conference 2026 is where this work begins. Here, stakeholders from across Europe come together to share best practice experiences, challenge assumptions, and co‑create practical solutions to optimise the system. Our goal is simple and ambitious: to strengthen participant protection while enabling efficient, faster, more predictable clinical trial authorisations and start up times.

Together, we have the opportunity to build an ethical review model that reflects Europe at its best—responsible, collaborative, transparent and ready to lead the next chapter of global research.

 

NEW:
Registering to this event now grant free participation to the complementary Virtual Pre-Conference Workshop, select "Combined Events" after clicking on "Register Here" on this page to benefit from this offer.
Join us early on site on the 12th of May to get the opportunity to Network with colleagues around a coffee, and enjoy a Lunch* before the Main Conference starts!
A Networking Dinner* is also planned on the 12th of May evening, after the closure of the day.

*Registrants will be contacted after settling their registration on the website to confirm their participation to networking events and provide their diet requirements.

With the Support of

Gold
Bronze
Regular

Programme

Tuesday 12 May 2026
09:30 Welcome Desk and Registrations Opening
09:30 Welcome coffee, networking, and discussions in the lobby
12:00 Networking Lunch
13:00 Welcome and Introduction to the EFGCP Conference 2026
Angelika Joos, MSD
Ingrid Klingmann, Pharmaplex, EFGCP
Jozef Glaza, Slovak Medical University in Bratislava, EFGCP
13:15 Session 1: The current situation of clinical trials and their ethical review in 4 years under the CTR
Moderator(s): Angelika Joos, MSD Mary-Lynne Van Poelgeest-Pomfret, World Federation of Incontinent Patients, EFGCP
Clinical Trials – Current conditions impacting EU attractiveness between perceptions and reality
Christopher Bamford, IQVIA
Industry perspective on EU competitiveness
Manan Trivedi, UCB
European Commission proposal for the BioTech Act to foster European competitiveness in clinical research
Corinna Hartung, European Commission, DG Santé
14:30 Coffee Break
14:45 Break-out Sessions on experiences with national Ethics Committee Systems
Break-out Group 1 – Decentralised Model (F2F Attendance Only)
Moderator(s): Christopher Bamford, IQVIA Ingrid Klingmann, Pharmaplex, EFGCP
Belgium
Jelle Klein, SGS Belgium NV Katelijne Anciaux, Clinical Trial College
France
Jean-Marc Davy, Commission nationale des recherches impliquant la personne humaine (CNRIPH) Seif Eddine Amara Madi, GSK
Germany
Robert Schultz-Heienbroek, Charité Research Organisation
Italy
Cinzia Dorigo, Alexion Roberto Poscia, National Coordination Center for Regional Ethics Committees
Spain
Elena Garcia Mendez, Ethics Committee of Hospital Universitario La Paz Maria Sanchez, MSD
The Netherlands
Amos de Jong, University Medical Centre Utrecht Michel Zwaan, Princes Maxima Centrum
Break-out Group 2 – Centralized Model (F2F Attendance Only)
Moderator(s): Birka Lehmann, University Bonn Jozef Glaza, Slovak Medical University in Bratislava, EFGCP
Estonia
Janek Kapper, Estonian Inflammatory Bowel Disease Association
Denmark
Kaja Borup Løvschall, Danish Health Authority, National Center for Ethics
Finland
Marko Ahteensuu, Tukija, Finnish Ethics Committee Supervisory Agency
Greece
Varvara Baroutsou, IFAPP
Poland
Aneta Sitarska Haber, Polish Association for Good Clinical Practice Monika Trawinska, Medical Research Agency
Portugal
Rafael Vale e Reis, University of Coimbra Sonia Carvalho, AICIB
Slovakia
Helena Glasová, Slovak Medical University
Virtual Break-out Group Open 3 – Global experience: What experience tells us about successful elements of clinical review in different countries: Trust or Trustworthiness? (Online Attendance Only)
Moderator(s): Heather Sampson, University of Toronto, EFGCP Hugh Davies, Oxford A Research Ethics Committee
17:00 Jozef Hoet Award Ceremony
Ingrid Klingmann, Pharmaplex, EFGCP
18:00 Close of the Day and Networking Dinner
Wednesday 13 May 2026
08:30 Welcome Coffee
09:00 Session 2: What can we learn from each other?
Moderator(s): Helle Christiansen, Danish National Center for Ethics Solange Corriol-Rohou, Consultant, EFGCP
10:45 Coffee Break
Session 3: How can we increase Europe’s competitiveness while ensuring leading ethical review standards and optimal participant protection?
Moderator(s): Blanca Garcia-Ochoa, MSD Joop van Gerven, Chair MERB Amsterdam UMC
11:15 MedEthicsEU: Current and planned future approach to harmonisation and facilitation of ethical review
Monique Al, CCMO, MedEthics EU
11:45 Open Forum Discussion
Introduction: European Commission Proposal for Revising the Clinical Trials Regulation with a Focus on the Ethical Review Corinna Hartung, European Commission DG Santé
Corinna Hartung, European Commission, DG Santé
Discussion: What needs to be done to ensure reliable, efficient ethical review in the coordinated assessment procedure? Will Fast-EU provide the pilot testbed?
Cinzia Dorigo, Alexion
Corinna Hartung, European Commission, DG Santé
Dominique Sprumont, EUREC, CIOMS, Ethics committee of Vaud
Manan Trivedi, UCB
Monique Al, CCMO, MedEthics EU
13:00 Panel and Open Forum Discussion and Slido collection of opinions from the audience onsite and online: Recommendations for the future ethical review of clinical trials from the EFGCP Conference 2026 multi-stakeholder participants
Angelika Joos, MSD
Ingrid Klingmann, Pharmaplex, EFGCP
Jozef Glaza, Slovak Medical University in Bratislava, EFGCP
13:45 Conclusions and next steps